|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.207 USD | +2.78% |
|
+0.93% | -78.32% |
| Apr. 01 | UBS Trims CareMax Price Target to $6.40 From $7, Maintains Neutral Rating | MT |
| Mar. 18 | Transcript : CareMax, Inc., Q4 2023 Earnings Call, Mar 18, 2024 |
CareMax, Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported revenue was USD 151.84 million compared to USD 164.26 million a year ago. Net loss was USD 465.77 million compared to net income of USD 10.43 million a year ago.
Basic loss per share from continuing operations was USD 124.53 compared to basic earnings per share from continuing operations of USD 3.1 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -78.32% | 11.86M | |
| -14.56% | 84.68B | |
| +14.93% | 81.12B | |
| +10.49% | 29.59B | |
| -8.91% | 16.73B | |
| -1.39% | 16.36B | |
| -31.58% | 11.77B | |
| +1.82% | 11.72B | |
| +31.13% | 11.71B | |
| -0.47% | 11.66B |
CAREMAX, INC. 
